| Axon ID |
Name |
Description |
From price |
|
1128
|
Erlotinib hydrochloride
|
EGFR tyrosine kinase inhibitor |
€70.00 |
|
1393
|
Gefitinib
|
EGFR tyrosine kinase inhibitor |
€70.00 |
|
1395
|
Lapatinib ditosylate
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€80.00 |
|
1411
|
Vandetanib
|
VEGFR and EGFR tyrosine kinase inhibitor |
€50.00 |
|
1433
|
CI 1033
|
EGFR tyrosine kinase inhibitor |
€60.00 |
|
1506
|
WZ 4002
|
EGFR kinase inhibitor (T790M specific) |
€70.00 |
|
1526
|
Neratinib
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€80.00 |
|
1537
|
CP 724714
|
ErbB-2/HER2 kinase inhibitor |
€80.00 |
|
1544
|
BIBW 2992
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€50.00 |
|
1548
|
LBH 589
|
HDAC1 Inhibitor |
€90.00 |
|
1632
|
OSI 420
|
EGFR tyrosine kinase inhibitor |
€90.00 |
|
1645
|
HDAC6 inhibitor ISOX
|
HDAC6 Inhibitor |
€110.00 |
|
1653
|
AEE 788
|
EGFR, ErbB2 and VEGFR tyrosine kinase inhibitor |
€80.00 |
|
1665
|
Pelitinib
|
EGFR tyrosine kinase inhibitor |
€90.00 |
|
1707
|
MC 1568
|
HDAC inhibitor (class IIA selective) |
€85.00 |
|
1760
|
EGFR Inhibitor [879127-07-8]
|
Highly selective EGFR tyrosine kinase inhibitor |
€120.00 |
|
1777
|
SB 939
|
HDAC inhibitor (1, 2, 4 Selective) |
€95.00 |
|
1801
|
Pyroxamide
|
HDAC1 Inhibitor |
€90.00 |
|
1803
|
MS 275
|
Inhibitor of HDAC (1 and 3 Selective) |
€60.00 |
|
1853
|
PCI 34051
|
HDAC8 Inhibitor |
€90.00 |
|
1986
|
AST 1306 tosylate
|
ErbB2 and EGFR inhibitor |
€90.00 |
|
2014
|
CI 994
|
HDAC inhibitor that causes histone hyperacetylation in living cells |
€70.00 |
|
2053
|
TAK 165
|
ErbB2/HER2 kinase inhibitor |
€60.00 |
|
2180
|
TMP 195
|
HDAC inhibitor (class IIA selective) |
€110.00 |
|
2195
|
RGFP 966
|
HDAC3 specific inhibitor |
€85.00 |
|
2209
|
Sodium butyrate
|
Noncompetitive inhibitor of multiple histone deacetylases (HDACs) |
€50.00 |
|
2342
|
AZD9291
|
Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs |
€95.00 |
|
2359
|
Nexturastat A
|
HDAC6 inhibitor with good selectivity over HDAC1 and HDAC8 |
€90.00 |
|
2471
|
BRD 73954
|
Dual HDAC 6/8 inhibitor with excellent selectivity over the other HDACs |
€85.00 |
|
2430
|
LW 479
|
HDAC inhibitor with cytotoxicity in a panel of breast cancer cell lines. |
€135.00 |
|
2495
|
Santacruzamate A
|
Picomolar level HDAC2 inhibitor with little inhibition of HDAC4 and HDAC6 |
€85.00 |
|
2505
|
Mocetinostat
|
Class I selective HDAC inhibitor with broad spectrum antitumor activity |
€80.00 |
|
2529
|
JNJ 26481585 dihydrochloride
|
Potent, orally available second-generation pan-HDAC inhibitor |
€125.00 |
|
2518
|
UF 010
|
Class I selective HDAC inhibitor that inhibits cancer cell proliferation |
€60.00 |
|
2563
|
AZD3759
|
Potent, orally active, brain-penetrant, EGFR tyrosine kinase inhibitor |
€85.00 |
|
2680
|
EAI045
|
Allosteric EGFR inhibitor (L858R/T790M-specific) |
€105.00 |
|
2394
|
AR-42
|
HDAC inhibitor |
€125.00 |
|
2893
|
Tucidinostat
|
Orally bioavailable HDAC inhibitor (1, 2, 3, 10 Selective) |
€95.00 |
|
2004
|
Tubastatin A hydrochloride
|
Potent and selective HDAC6 inhibitor |
€95.00 |
|
2920
|
Poziotinib
|
Irreversible pan-HER inhibitor |
€95.00 |
|
2955
|
NSC 228155
|
EGFR tyrosine kinase activator; Inhibitor of KIX-KID interaction |
€75.00 |
|
2996
|
TH 34
|
HDAC inhibitor (6, 8, 10 Selective) |
€120.00 |
|
3038
|
CXD101
|
HDAC inhibitor (1, 2, 3 Selective) |
€125.00 |
|
3039
|
ACY-241
|
Selective and orally available HDAC6 inhibitor |
€120.00 |
|
3040
|
Abivertinib
|
Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs |
€95.00 |
|
3114
|
Vorinostat
|
HDAC inhibitor |
€45.00 |
|
3115
|
Belinostat
|
HDAC inhibitor |
€70.00 |
|
3192
|
EMI48
|
Inhibitor of EGFR triple mutants |
€120.00 |
|
3232
|
TAK-788
|
Potent and selective EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€70.00 |
|
3235
|
Dacomitinib
|
Potent irreversible pan-HER inhibitor |
€60.00 |
|
3397
|
BG45
|
HDAC inhibitor (1, 2, 3 Selective) |
€80.00 |
|
3399
|
BML-210
|
HDAC inhibitor |
€80.00 |
|
3409
|
NKL 22
|
HDAC inhibitor |
€80.00 |
|
3691
|
Tubacin
|
HDAC6 inhibitor |
Inquire |
|
3802
|
TAS6417
|
EGFR inhibitor |
Inquire |
|
3853
|
BMS-599626
|
Potent and selective EGFR and ErbB2 inhibitor |
Inquire |
|
3862
|
BGB-283
|
Orally available dual RAF kinase/EGFR inhibitor |
Inquire |
|
3995
|
WT-161
|
Potent,selective,and bioavailable HDAC6 inhibitor |
Inquire |
|
3989
|
Givinostat hydrochloride
|
Orally active HDAC inhibitor |
€95.00 |
|
4034
|
SR-4370
|
Synthetic inhibitor of histone deacetylase (HDAC) |
Inquire |
|
4074
|
AZ5104
|
EGFR inhibitor |
Inquire |
|
4099
|
Martinostat hydrochloride
|
HDAC inhibitor (1, 2, 3, 6 Selective) |
€120.00 |
|
4144
|
Olmutinib
|
Orally bioavailable and irreversible Tyrosine Kinase Inhibitor |
Inquire |
|
4238
|
M344
|
Potent HDAC inhibitor |
€95.00 |